A Memorandum of Understanding was signed between India and Netherlands for development of vaccines. It will enable the Bharat Immunologicals and Biologicals Corporation Ltd (BIBCOL) to develop Measles – Rubella vaccine at Chola, Bulandshahr, U.P. Translational Vaccinology (INTRAVACC) a government-based institute of the Netherlands will extend support for development of vaccine. The MoU was signed in the presence of the Prime Minister of The Netherlands Mark Rutte. INTRAVACC, an institute which is part of the Ministry of Health, Welfare and Sport of the Netherlands, is internationally renowned for vaccine development and has a long history in technology transfer.
BIBCOL, Bulandshahar, UP established in 1989 is aimed at achieving self-sufficiency in production and supply of high quality polio vaccine and other biologicals. Minister for Science & Technology Harshvardhan said that in the post polio eradication era the focus shall be on elimination / control of other vaccine preventable diseases such as measles and rubella. Chairman, BIBCOL, M.K. Bhan said the MoU will pave the way for manufacture of high quality affordable vaccines beginning with Measles and Rubella and production of other vaccines for immunization programmes.